down arrow

Bayit Bakfar Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IL0011836561
ILS
14.87
-0.09 (-0.6%)

Dec 04

TAE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Bayit Bakfar Ltd.
Why is Bayit Bakfar Ltd. ?
1
Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months
  • Poor long term growth as Net Sales has grown by an annual rate of 6.32% and Operating profit at 4.17%
2
With ROE of 2.15%, it has a Very Expensive valuation with a 0.90 Price to Book Value
  • Over the past year, while the stock has generated a return of 8.78%, its profits have fallen by -17.4%
3
Underperformed the market in the last 1 year
  • The stock has generated a return of 8.78% in the last 1 year, much lower than market (Israel TA-100) returns of 48.91%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Bayit Bakfar Ltd. for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
Bayit Bakfar Ltd.
10.15%
1.43
27.24%
Israel TA-100
49.53%
2.91
16.81%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
6.32%
EBIT Growth (5y)
4.17%
EBIT to Interest (avg)
3.26
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.10
Tax Ratio
23.51%
Dividend Payout Ratio
22.53%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.08%
ROE (avg)
2.64%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
42
Industry P/E
Price to Book Value
0.90
EV to EBIT
19.57
EV to EBITDA
19.33
EV to Capital Employed
0.88
EV to Sales
7.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
4.51%
ROE (Latest)
2.15%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."